Leon Caly
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Virology top 2%
- Poxvirus research and outbreaks
Papers in
-
- SARS-CoV-2 and COVID-19 Research 18
- SARS-CoV-2 detection and testing 6
- Virology 10
- HIV Research and Treatment 5
- Poxvirus research and outbreaks 5
- Co-authors
- Julian D Druce (19 shared papers)David A. Jans (11 shared papers)Kylie M. Wagstaff (2 shared papers)Mike G Catton (2 shared papers)Sharon R. Lewin (2 shared papers)Mike C Catton (5 shared papers)Steven Y. C. Tong (2 shared papers)Suellen R Nicholson (3 shared papers)
- Journals
- The Lancet Microbe (5 papers)Nature Medicine (4 papers)Viruses (4 papers)Antiviral Research (2 papers)Pathology (2 papers)
- Partner nations
- AustraliaUnited KingdomSwitzerland
In The Last Decade
Leon Caly
51 papers receiving 4.2k citations
Leon Caly's Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 2.8k
- Virology 291
- Modeling and Simulation 112
- General Dentistry 6
- Computational Theory and Mathematics 204
Countries citing papers authored by Leon Caly
This map shows the geographic impact of Leon Caly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Caly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Caly more than expected).
Fields of papers citing papers by Leon Caly
This network shows the impact of papers produced by Leon Caly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Caly. The network helps show where Leon Caly may publish in the future.
Co-authors
The 25 scholars most cited alongside Leon Caly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro Hit paper breakdown → | 2020 | 1608 |
| 2 | 2020 | 816 | |
| 3 | 2020 | 419 | |
| 4 | 2020 | 251 | |
| 5 | 2021 | 190 | |
| 6 | 2022 | 131 | |
| 7 | 2020 | 129 | |
| 8 | 2012 | 95 | |
| 9 | 2022 | 77 | |
| 10 | 2022 | 61 | |
| 11 | 2021 | 53 | |
| 12 | 2015 | 48 | |
| 13 | 2023 | 41 | |
| 14 | 2003 | 39 | |
| 15 | 2014 | 34 | |
| 16 | 2008 | 31 | |
| 17 | 2021 | 30 | |
| 18 | 2022 | 29 | |
| 19 | 2017 | 28 | |
| 20 | 2018 | 28 |
About Leon Caly
Leon Caly is a scholar working on Infectious Diseases, Virology, Public Health, Environmental and Occupational Health, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 55 papers that have together received 4.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (18 papers), Mosquito-borne diseases and control (11 papers), Respiratory viral infections research (8 papers), SARS-CoV-2 detection and testing (6 papers), HIV Research and Treatment (5 papers), Poxvirus research and outbreaks (5 papers), Virology and Viral Diseases (4 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Infectious Diseases (2.8k citations), Virology (291 citations), Modeling and Simulation (112 citations), General Dentistry (6 citations) and Computational Theory and Mathematics (204 citations). Leon Caly has collaborated with scholars based in Australia, United Kingdom and Switzerland. Frequent co-authors include Julian D Druce, David A. Jans, Kylie M. Wagstaff, Mike G Catton, Sharon R. Lewin, Mike C Catton, Steven Y. C. Tong, Suellen R Nicholson, Irani Thevarajan and Carolien E. van de Sandt. Their work appears in journals such as The Lancet Microbe, Nature Medicine, Viruses, Antiviral Research and Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.